摘要 |
Provided herein is a method for detecting an HPA axis function marker in a biological sample. The method may be used to determine whether a patient is a suitable candidate for treatment with a V1B antagonist. The HPA marker may be a genomic marker, non-genomic marker, or a combination thereof. Depending on the type of HPA marker, the method of detection can be an immunoassay or genotyping, for example.
|